EP3332036 - GENETIC ABNORMALITIES IN PLASMA CELL DYSCRASIAS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 05.01.2024 Database last updated on 19.10.2024 | |
Former | Grant of patent is intended Status updated on 10.04.2023 | ||
Former | Examination is in progress Status updated on 24.02.2020 | ||
Former | Request for examination was made Status updated on 11.05.2018 | ||
Former | The international publication has been made Status updated on 18.02.2017 | Most recent event Tooltip | 05.01.2024 | Application deemed to be withdrawn | published on 07.02.2024 [2024/06] | Applicant(s) | For all designated states Dana-Farber Cancer Institute, Inc. 450 Brookline Avenue Boston, MA 02115-5450 / US | [2018/24] | Inventor(s) | 01 /
GHOBRIAL, Irene 1 Chatham Circle Wellesley, Massachusetts 02481 / US | 02 /
MANIER, Salomon 39 Rue Nicolas Leblanc Apt. 5222 59000 Lille / FR | 03 /
MISHIMA, Yuji 1-2-11-1910 Ariake Koto-ku Tokyo 135-0063 / JP | [2018/24] | Representative(s) | Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | [N/P] |
Former [2018/24] | Pohlman, Sandra M. df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB Theatinerstrasse 16 80333 München / DE | Application number, filing date | 16835701.0 | 05.08.2016 | [2018/24] | WO2016US45815 | Priority number, date | US201562202314P | 07.08.2015 Original published format: US 201562202314 P | [2018/24] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2017027391 | Date: | 16.02.2017 | Language: | EN | [2017/07] | Type: | A2 Application without search report | No.: | EP3332036 | Date: | 13.06.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.02.2017 takes the place of the publication of the European patent application. | [2018/24] | Search report(s) | International search report - published on: | US | 19.04.2018 | (Supplementary) European search report - dispatched on: | EP | 10.07.2019 | Classification | IPC: | C12Q1/68, G01N33/49, G01N33/50 | [2019/19] | CPC: |
C12Q1/6886 (EP,US);
A61P35/02 (EP,US);
C12Q1/6883 (EP,US);
G01N33/5011 (US);
G01N33/5038 (US);
G01N33/5044 (US);
G01N33/574 (US);
C12Q2600/112 (EP,US);
C12Q2600/118 (EP,US);
C12Q2600/154 (EP,US);
C12Q2600/156 (EP,US);
C12Q2600/158 (EP,US);
G01N2570/00 (US);
G01N2800/22 (US);
G01N2800/52 (US);
|
Former IPC [2019/03] | C12N15/113, C12Q1/68, G01N33/49, G01N33/50 | ||
Former IPC [2018/24] | C12Q1/68 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/24] | Title | German: | GENETISCHE ANOMALIEN BEI PLASMAZELLENDYSKRASIE | [2018/24] | English: | GENETIC ABNORMALITIES IN PLASMA CELL DYSCRASIAS | [2018/24] | French: | ANOMALIES GÉNÉTIQUES DANS DES DYSCRASIES DE CELLULES DU PLASMA | [2018/24] | Entry into regional phase | 19.02.2018 | National basic fee paid | 19.02.2018 | Search fee paid | 19.02.2018 | Designation fee(s) paid | 19.02.2018 | Examination fee paid | Examination procedure | 19.02.2018 | Examination requested [2018/24] | 19.02.2018 | Date on which the examining division has become responsible | 04.02.2020 | Amendment by applicant (claims and/or description) | 26.02.2020 | Despatch of a communication from the examining division (Time limit: M04) | 18.06.2020 | Reply to a communication from the examining division | 01.09.2020 | Despatch of a communication from the examining division (Time limit: M06) | 11.02.2021 | Reply to a communication from the examining division | 19.05.2021 | Despatch of a communication from the examining division (Time limit: M06) | 23.11.2021 | Reply to a communication from the examining division | 31.05.2022 | Despatch of a communication from the examining division (Time limit: M04) | 21.09.2022 | Reply to a communication from the examining division | 11.04.2023 | Communication of intention to grant the patent | 22.08.2023 | Application deemed to be withdrawn, date of legal effect [2024/06] | 13.09.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2024/06] | Divisional application(s) | EP23192034.9 / EP4286847 | Fees paid | Renewal fee | 27.08.2018 | Renewal fee patent year 03 | 27.08.2019 | Renewal fee patent year 04 | 27.08.2020 | Renewal fee patent year 05 | 27.08.2021 | Renewal fee patent year 06 | 29.08.2022 | Renewal fee patent year 07 | 28.08.2023 | Renewal fee patent year 08 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]WO2013134786 (CARIS LIFE SCIENCES LUXEMBOURG HOLDINGS S A R L [LU], et al); | International search | [A]US2013171124 (CONG LE [US], et al); | [XY]WO2014071205 (DANA FARBER CANCER INST INC [US]); | [Y]US2014364439 (WU CATHERINE J [US], et al); |